Prostaglandins F, Synthetic
"Prostaglandins F, Synthetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF.
Prostaglandins F, Synthetic
- Prostaglandins F, Synthetic
- Synthetic Prostaglandins F
- PGF Synthetic
- Synthetic, PGF
- Prostaglandin F Analogues
- Analogues, Prostaglandin F
- Prostaglandin F Analogs
- Analogs, Prostaglandin F
Below are MeSH descriptors whose meaning is more general than "Prostaglandins F, Synthetic".
Below are MeSH descriptors whose meaning is more specific than "Prostaglandins F, Synthetic".
This graph shows the total number of publications written about "Prostaglandins F, Synthetic" by people in Harvard Catalyst Profiles by year, and whether "Prostaglandins F, Synthetic" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
Below are the most recent publications written about "Prostaglandins F, Synthetic" by people in Profiles.
Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma. Eur J Ophthalmol. 2022 Jan; 32(1):322-326.
Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys. Ophthalmology. 2016 10; 123(10):2085-92.
Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study. JAMA Ophthalmol. 2014 Jul; 132(7):838-44.
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. Biomaterials. 2014 Jan; 35(1):432-9.
A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features. PLoS One. 2013; 8(5):e61638.
Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma. Invest Ophthalmol Vis Sci. 2012 Jun 20; 53(7):3733-41.
A study of initial therapy for glaucoma in southern India: India Glaucoma Outcomes and Treatment (INGOT) Study. Ophthalmic Epidemiol. 2012 Jun; 19(3):149-58.
Intraocular pressure-lowering effect of 0.005% latanoprost with two different dosing regimens. J Ocul Pharmacol Ther. 2012 Oct; 28(5):524-8.
Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma. J Ocul Pharmacol Ther. 2011 Oct; 27(5):499-502.
Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. Br J Ophthalmol. 2012 Feb; 96(2):250-3.